Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Nasdaq Biotechnology Ishares ETF (NQ: IBB)
113.97 USD  +1.03 (+0.91%)
Official Closing Price  /  Updated: 7:53 PM EDT, Apr 9, 2020  /  Add to My Watchlist      
View: Quote News
Fund Overview
Nasdaq Biotechnology Ishares ETF
Sector
Exchange Traded NQ
Net Assets 9.91B
Inception Date
Related Funds
Quote
Price 113.97
Volume 2,762,900
Last Trade Apr 09, 7:53pm
Change (%)
+1.03 (0.91%)
Prev. Close 112.94
YTD %
-4.94%
Dividend Yield 0.27%
Performance
YTD
-5.92 (-4.94%)
1 Month
+1.66 (1.48%)
3 Month
-7.07 (-5.84%)
6 Month
+14.97 (15.12%)
1 Year
+0.13 (0.11%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Pfizer, BioNTech, Arcturus Share Timelines For Human Testing As COVID-19 Vaccine Development Intensifies
The enormity of the coronavirus pandemic has forced biopharma companies to step up efforts to expeditiously develop vaccinesand ... Read More
from Benzinga
Prepare for massive new opportunities in stocks as the response to the coronavirus reshapes the economy
There will be a big shift in the economy, helping the likes of biotechnology and semiconductor stocks. Read More
from MarketWatch
Top News
More News
Noteworthy ETF Inflows: IBB, GILD, VRTX, AMGN
Symbols mentioned in this story: IBB, GILD, VRTX, AMGN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
from ETF Channel
The Daily Biotech Pulse: FDA Nod For Pfizer, Vanda Forges Partnership For COVID-19 Drug Research, Neuronetics Pre-Announces Revenue Shortfall
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... Read More
from Benzinga
A Market Only As Good As Its Lowest Common Denominator
KRE was the first to fall into a caution phase in January. A while ago, we fathomed that it stands to reason it should also be the first to show a true bottom. At this point, KRE is the lowest common... Read More
from Blogs - TalkMarkets
First Week of IBB May 22nd Options Trading
Investors in iShares Trust - iShares Nasdaq Biotechnology ETF (IBB) saw new options become available this week, for the May 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked... Read More
from Market News Video
The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
The Russell 2000’s Weekly Bear Flag Setup
The Russell 2000 IWM weekly chart has helped us navigate the bull and bear runs for years. Read More
from Blogs - TalkMarkets
The Daily Biotech Pulse: Sanofi, Regeneron Finalize Praluent Restructuring, Natus Pre-Announces Q1 Shortfall, Alcon To Delay Dividend Initiation
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... Read More
from Benzinga
30 Top Stocks and Funds to Beat the COVID-19 Bear Market
If you want to grow your capital in this bear market, these 30 names should be on your radar right now. Read More
from Motley Fool
The Week Ahead In Biotech: Spotlight On Q1 Pre-Announcements As COVID-19 Continues To Disrupt Operations
Biotech stocks went along with the broader market flow in the week ended April 3, with the COVID-19 pandemic dictating sentiment. The ... Read More
from Benzinga
The Year of the Rat: Have They FED on Money Supply?
Over the last three weeks, the M2 money supply has exploded by a whopping $532 billion. Money supply is expanding at 26x the rate of QE1 during the 2008 financial crisis. Read More
from Blogs - TalkMarkets
Analysts See 37% Gains Ahead For The Holdings of IBB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... Read More
from ETF Channel
The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation
Here's a roundup of top developments in the biotech space over the last 24 hours. On a day when the three major averages shed ... Read More
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.